U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07887997) titled 'Temporal Interference Stimulation (TI) for Schizophrenia (SCZ)' on Oct. 15.
Brief Summary: This study will evaluate whether temporal interference (TI) stimulation, added to usual clinical treatment, improves symptoms of schizophrenia and is safe and tolerable. Approximately 100 adults aged 18 to 60 years with schizophrenia will be randomly assigned in equal numbers to active TI or sham TI. Participants and researchers assessing treatment outcomes will not know which treatment has been assigned.
Participants will continue usual clinical treatment and receive two 30-minute stimulation sessions daily for 14 consecutive days, for a tot...